Trabectedin is an effective second-line treatment in soft tissue sarcoma patients

Ann Oncol. 2016 Mar;27(3):551-2. doi: 10.1093/annonc/mdv585. Epub 2015 Nov 24.

Authors

C Peugniez¹, S Cousin², N Penel³

Affiliations

¹ Department of Medical Oncology, Centre Oscar Lambret, Lille Medical School of Catholic University, Lille.
² Department of Medical Oncology, Centre Oscar Lambret, Lille.
³ Department of Medical Oncology, Centre Oscar Lambret, Lille SIRIC OncoLille Consortium, Clinical Research and Methodology Platform, Lille, France n-penel@o-lambret.fr.

PMID: 26602777
DOI: 10.1093/annonc/mdv585

No abstract available

Publication types

Letter

MeSH terms

Dacarbazine / therapeutic use
Dioxoles / therapeutic use*
Disease-Free Survival
Humans
Sarcoma / drug therapy*
Tetrahydroisoquinolines / therapeutic use*
Trabectedin

Substances

Dioxoles
Tetrahydroisoquinolines
Dacarbazine
Trabectedin